These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1942523)

  • 1. [An improved method for biochemical measurement of the activity of neutrophil alkaline phosphatase and its application to myeloproliferative disorders].
    Tokuda M; Kawanishi K; Irino S
    Rinsho Ketsueki; 1991 Aug; 32(8):838-43. PubMed ID: 1942523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase-deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders.
    Bendix-Hansen K
    Scand J Haematol; 1986 Jan; 36(1):8-10. PubMed ID: 3006224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukocyte alkaline phosphatase and glucose-6-phosphate-dehydrogenase of the erythrocytes in differential diagnosis of chronic myeloproliferative diseases (author's transl)].
    Hennemann HH; Schief A
    Med Klin; 1974 Aug; 69(34):1359-63. PubMed ID: 4530151
    [No Abstract]   [Full Text] [Related]  

  • 4. [The activity of the alkaline phosphatase of neutrophils in myeloproliferative diseases].
    Vakulenko AD; Shubich MG
    Ter Arkh; 1966 Feb; 38(2):66-9. PubMed ID: 5235224
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neutrophil alkaline phosphatase score].
    Nakamura Y; Waga K; Mitani K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():785-8. PubMed ID: 15658450
    [No Abstract]   [Full Text] [Related]  

  • 7. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neutrophil alkaline phosphatase (NAP) score].
    Aoyagi M; Furusawa S
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():221-4. PubMed ID: 8753222
    [No Abstract]   [Full Text] [Related]  

  • 9. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of neutrophil alkaline phosphatase (NAP) activity in untreated myeloproliferative syndromes and in leukaemoid reactions.
    Bendix-Hansen K; Bergmann OJ
    Scand J Haematol; 1985 Aug; 35(2):219-24. PubMed ID: 4048868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemiluminescence of neutrophils in patients with myeloproliferative or myelodysplastic hematologic diseases--relation to neutrophil alkaline phosphatase activity.
    Wakita H; Asai T; Oh H; Itoh K; Yoshida S
    Intern Med; 1993 Mar; 32(3):204-9. PubMed ID: 7687168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative disorders and laboratory correlates.
    Sirhan S; Lasho TL; Elliott MA; Tefferi A
    Haematologica; 2005 Mar; 90(3):406-8. PubMed ID: 15749676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unusual case of chronic myeloproliferative syndrome].
    Tosato F; Fossaluzza V
    Arch Sci Med (Torino); 1982; 139(4):531-5. PubMed ID: 6891999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD16 antigen density on neutrophils in chronic myeloproliferative disorders.
    Kabutomori O; Iwatani Y; Koh T; Yanagihara T
    Am J Clin Pathol; 1997 Jun; 107(6):661-4. PubMed ID: 9169662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation by retinoids and interferons of alkaline phosphatase activity in granulocytes induced by granulocyte colony-stimulating factor.
    Sato N; Takatani O; Koeffler HP; Sato H; Asano S; Takaku F
    Exp Hematol; 1989 Mar; 17(3):258-62. PubMed ID: 2465168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochemical alkaline phosphatase test of mature neutrophils in the different diagnosis of myeloproliferative disorders.
    BLUM LL
    J Indiana State Med Assoc; 1962 Dec; 55():1783-4. PubMed ID: 13971867
    [No Abstract]   [Full Text] [Related]  

  • 18. Semi-Automatic Rating Method for Neutrophil Alkaline Phosphatase Activity.
    Sugano K; Hashi K; Goto M; Nishi K; Maeda R; Kono K; Yamamoto M; Okada K; Kaga S; Miwa K; Mikami T; Masauzi N
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27377175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
    Pikman Y; Levine RL
    Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.